These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 6069927)

  • 41. A COMPARISON OF HUMAN AND GUINEA PIG COMPLEMENTS AND THEIR COMPONENT FRACTIONS.
    Bier OG; Leyton G; Mayer MM; Heidelberger M
    J Exp Med; 1945 May; 81(5):449-68. PubMed ID: 19871469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of adenylic acid with alkaline earth metal ions in the crystalline solid and aqueous solution. Evidence for the sugar C'2-endo/anti, C'3-endo/anti and C'4-exon/anti conformational changes.
    Tajmir-Riahi HA
    Biochim Biophys Acta; 1990 Sep; 1087(1):49-54. PubMed ID: 2119235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Behavior of the 3rd and 4th complement fractions (C'3 and C'4) in hepatic cirrhosis].
    Díaz-Rubio García M; Enríquez L; Erroz A; Arroyo MJ; Zamarrón A; Díaz-Rubio García C; Díaz Rubio M
    Rev Clin Esp; 1974 Aug; 134(4):319-22. PubMed ID: 4445539
    [No Abstract]   [Full Text] [Related]  

  • 44. Studies on the third component (C'3) of guinea pig complement. I. Purification and characterization.
    Yonematsu K; Inoue K
    Biken J; 1968 Sep; 11(3):169-80. PubMed ID: 4976235
    [No Abstract]   [Full Text] [Related]  

  • 45. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.
    NILSSON UR; MUELLER-EBERHARD HJ
    J Exp Med; 1965 Aug; 122(2):277-98. PubMed ID: 14316946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RELEASE OF HISTAMINE FROM RABBIT BLOOD CELLS BY AN ANAPHYLATOXIN-LIKE SUBSTANCE FORMED IN NORMAL AND C'3 DEFECT RABBIT PLASMA.
    GIERTZ H; REUTTER W; SCHMUTZLER W
    Nature; 1964 Jun; 202():1346. PubMed ID: 14210981
    [No Abstract]   [Full Text] [Related]  

  • 47. Quantitative studies on the properdin-complement system. II. Kinetics of the reaction between properdin and zymosan.
    LEON MA
    J Exp Med; 1957 May; 105(5):403-15. PubMed ID: 13428911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Levels of wo components of complement (C'4 and C'3) in human fetal and newborn sera.
    Adinolfi M
    Dev Med Child Neurol; 1970 Jun; 12(3):306-8. PubMed ID: 5433147
    [No Abstract]   [Full Text] [Related]  

  • 49. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.
    Bokisch VA; Müller-Eberhard HJ; Cochrane CG
    J Exp Med; 1969 May; 129(5):1109-30. PubMed ID: 5778786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CH50, C'2 and C'3 levels in patients of tuberculosis--a preliminary study.
    Ganguly NK; Arya D; Chitkara NL; Malik SK
    Indian J Pathol Microbiol; 1977 Oct; 20(4):243-9. PubMed ID: 614253
    [No Abstract]   [Full Text] [Related]  

  • 51. Separation of C'4 from C'1 inactivator and purification of both substances.
    Inai S; Hiramatsu S; Nagaki K
    Biken J; 1967 Sep; 10(3):155-74. PubMed ID: 4170106
    [No Abstract]   [Full Text] [Related]  

  • 52. COMPARISON OF THE AGGLUTINABILITY BY RHEUMATOID ARTHRITIC SERA OF SENSITIZED SHEEP CELLS, EXPOSED TO HUMAN C'1, C'4 AND C'2.
    LAURELL AB
    Acta Pathol Microbiol Scand; 1963; 59():73-8. PubMed ID: 14064807
    [No Abstract]   [Full Text] [Related]  

  • 53. Inherited deficiency of the third component of human complement (C'3).
    Alper CA; Propp RP; Klemperer MR; Rosen FS
    J Clin Invest; 1969 Mar; 48(3):553-7. PubMed ID: 5773091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolism of radiolabelled C'3 and C'4 in human renal allograft recipients.
    Carpenter CB; Ruddy S; Shehadeh IH; Merrill JP; Austen KF; Muller-Eberhard HJ
    Transplant Proc; 1969 Mar; 1(1):279-82. PubMed ID: 5002660
    [No Abstract]   [Full Text] [Related]  

  • 55. Anaphylatoxin in its relation to the complement system.
    Jensen J
    Science; 1967 Mar; 155(3766):1122-3. PubMed ID: 6021911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Serum-complement factors in the pseudo-LE syndrome (author's transl)].
    Kaboth U; Niederhut H; Brunner G
    Dtsch Med Wochenschr; 1977 Apr; 102(13):470-3. PubMed ID: 844426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic polymorphism of the third component of human complement (C'3).
    Alper CA; Propp RP
    J Clin Invest; 1968 Sep; 47(9):2181-91. PubMed ID: 5675433
    [TBL] [Abstract][Full Text] [Related]  

  • 58. C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT.
    MUELLER-EBERHARD HJ; LEPOW IH
    J Exp Med; 1965 May; 121(5):819-33. PubMed ID: 14280442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.
    MUELLER-EBERHARD HJ; BIRO CE
    J Exp Med; 1963 Sep; 118(3):447-66. PubMed ID: 14078003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of calcium ions on the inactivation of human complement and its components by plasmin.
    LEPOW IH; PILLEMER L; RATNOFF OD
    J Exp Med; 1953 Sep; 98(3):277-89. PubMed ID: 13084846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.